CNS Pharmaceuticals
CNSP | NASDAQ
$3.48
+$0.59 (+20.42%)
At close: Nov 16, 2026, 4:00 PM ET
$3.60
+$0.12 (+3.45%)
After-hours:
Nov 16, 2026, 5:54 PM ET
+20.42%
(1D)No price chart data available for 1D timeframe.
Rating
29.2
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #826/1021 (Top 81%)
Key Statistics
Market Data
Market Cap $5.09M
1D Range
2.96 3.55
52W Range
2.13 7.84
Valuation (TTM)
PE -0.15
PB 0.28
EV/EBITDA 0.89
Valuation (NTM)
Forward PE N/A
Forward PEG 0.00
Price Target $0.50
Cash Flow
FCF Yield -264.3%
SBC Adj. FCF Yield -266.4%
SBC Impact -0.8%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
N/A
Dil EPS 3Y | 5Y 149.5% |
92.0%
FCF 3Y | 5Y -8.9% |
-8.7%
Returns
ROA -76.1%
ROE -204.3%
ROIC -92.9%
Financial Health
Net Cash
$19.99M
Current Ratio 5.86
Interest Coverage -1,131.57
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical firm primarily focused on developing innovative anti-cancer therapies for tumors affecting the brain and central nervous system. Its primar...
Sector Healthcare
Industry Biotechnology
Employees 8
IPO Date Nov 8, 2019
Website www.cnspharma.com
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove CNSP